The relationship between hydrogen and methane production is a possible confounding factor in the interpretation of H 2 breath tests (HBT), but is usually disregarded for the interpretation of HBT and, in most instances, only H 2 excretion is measured. The present study was designed to evaluate the effect of predominant fasting methane CH 4 or H 2 production on the outcome of lactose HBT, in a large, homogeneous series of adult patients with irritable bowel syndrome (IBS). Patients and methods: A lactose HBT was performed in 237 IBS patients with predominant fasting methane production (CH 4 4H 2 ), recording the outcome of the test, amount of gas excreted and occurrence of clinical symptoms. Data were compared to those of 237 age-and sex-matched IBS patients with low fasting CH 4 excretion. Results: The test was positive in 124 predominant CH 4 producers (52.3%) (PMP), as compared to 201 (84.8%) low methane producers (LMP) (Po0.0001). Peak hydrogen concentration and area under the curve of H 2 were significantly (Po0.001) lower, and the occurrence of symptoms during the test less frequent, in PMP vs LMP patients. During the test, CH 4 excretion doubled in 57/113 (50.4%) patients with negative HBT, and in 49/124 (39.5%) with positive HBT. Conclusions: Patients with predominant fasting methane production excrete less H 2 than LMP, after an oral load of lactose. The lower prevalence of severe lactose intolerance in PMP, as well as lower incidence of symptoms during the test, is, indeed, related to lower and slower H 2 excretion. The assumption that H 2 excretion is an effective means of quantifying the amount of malabsorbed carbohydrates is questionable in PMP. Methane-producing patients likely have a higher 'false negative' rate as compared to LMP after an oral load of lactose. Nonetheless, as symptoms are related to the amount of gas produced in the colon, HBT identifies patients with 'lactose intolerance', irrespective of the presence of lactose malabsorption, and helps in predicting the effect of lactose-restricted diet.
Introduction
The microbial flora of the colon presents, in each gram of faeces, billions of organisms from 17 different bacterial families and about 500 classified species. The balance of individual species is rapidly influenced by the differing availability of substrates, changes in colonic content and complex interrelationships ranging from commensalism to competition. Not surprisingly, the possibility of studying the metabolic end-products of this complex ecosystem and the processes involved in their production is limited. Nonetheless, hydrogen breath tests (HBT) are commonly used in clinical practice for the diagnosis of carbohydrate malabsorption, as the concentration of breath hydrogen (H 2 ) parallels the intestinal production from fermented carbohydrates (Rosado & Solomons, 1983) . No relevant clinical use has so far been identified for the measurement of methane (CH 4 ) (Bjorneklett & Janssen, 1982; Mc Kay et al, 1985) , another important end product of the metabolism of the strictly anaerobic Archeobacteria. In contrast to hydrogen, CH 4 concentration remains relatively constant during the day, and does not depend directly upon the availability of fermentable substrate (Levitt & Bond 1970; Peled et al, 1987) . Methane production consumes 4 mol of H 2 to reduce 1 mol of CO 2 to CH 4 , a process greatly reducing the volume of gas in the colon.
The relation between H 2 and CH 4 production has been indeed considered a possible confounding factor in the interpretation of HBT. Some authors concluded that CH 4 production can be disregarded in the interpretation of HBT, as in children a positive correlation is found between the magnitude of the rise in CH 4 and H 2 concentrations (Montes et al, 1993) . However, it has been reported that evaluation of breath CH 4 might enhance the accuracy of HBT (Corazza et al, 1994) and that a decreased prevalence of CH 4 production is observed in lactose malabsorbers (Cloarec et al, 1991) . Despite these discrepancies, CH 4 production is usually disregarded in the interpretation of HBT and in most instances, only H 2 excretion is measured.
The present study was designed to throw further light on this issue, evaluating the effect of predominant fasting CH 4 or H 2 production on the outcome of lactose HBT, in a large, homogeneous series of adult IBS patients.
Patients and methods
Between 1994 and 2001, 744 consecutive outpatients with a diagnosis of irritable bowel syndrome (IBS), based on the Rome criteria (Thompson et al, 1989) , and referred to our laboratory to evaluate lactose tolerance by means of an HBT, were considered eligible for this study. Patients with IBS were chosen to participate in the study, being the largest homogeneous group undergoing a lactose HBT as part of their diagnostic protocol. Of these, 237 had predominant fasting methane production (PMP) (CH 4 4H 2 ), with a concentration of methane exceeding 10 parts per million (ppm). Data from these patients were compared with those of 237 age-and sex-matched IBS patients, from the same patient series, with fasting methane o5 ppm and predominant (H 2 4CH 4 ) fasting hydrogen excretion (low methane producersFLMP). The two groups comprised 79 males, mean age7s.d. 36.1714.5 y (range 18-79), and 158 females, mean age 38.2712.6 y (range 17-78). Data from 270 LMP were not taken into account as they could not be matched with patients from the other group.
After 24 h on a low-fibre diet and 12-h fasting, an HBT (Bond & Levitt, 1977) was performed following an oral load of lactose, at a dose of 0.5 g/kg body weight up to a maximum of 25 g. End-alveolar air samples were collected in syringes using a modified Haldane-Priestley tube (Metz et al, 1976) , prior to the administration of lactose, and thereafter every 30 min for 4 h. Hydrogen and methane concentrations were measured in ppm by means of a Quintron Model DP Microlyzer gas chromatograph (Quintron Instruments, Milwaukee, WI, USA). The test was defined as 'positive' when an H 2 or methane peak exceeding 20 ppm over the baseline values was observed in two or more samples. Tests not fulfilling the above-mentioned criteria were defined as negative. Those patients with a negative HBT, who did not excrete increased amounts of H 2 or CH 4 after oral administration of 20 g lactulose in a subsequent HBT, were defined as hydrogen non producers. A positive test identified patients with lactose malabsorption, irrespective of the presence or absence of abdominal symptoms characteristic of lactose intolerance.
The excretion of fermentation gas was quantified as: (a) the peak hydrogen/methane concentration (C max ), (b) the area under the curve of hydrogen/methane concentration from 60 to 240 min calculated with the triangular rule and expressed in arbitrary units of ppm/h (C tot ), and (c) the time elapsed between administration of lactose and the first peak of increased hydrogen/methane excretion (T peak ), as defined above. Increases in hydrogen excretion occurring during the first 30 min, if present, were not taken into account as likely deriving from substrate fermentation by oral flora.
Symptoms and bowel movements occurring during the test and in the 4 h thereafter were also recorded.
Statistics. Data were analysed using the w 2 test and the Mann-Whitney test.
Results
Lactose malabsorptionFoverall results. The lactose HBT was positive, as defined above, in 124/237 PMP IBS patients (52.3%, 35 males, 89 females), negative in 80/237 (33.7%, 33 males, 47 females), while 33 patients were classified as H 2 nonproducers (13.9%, 11 males, 22 females) (Figure 1 ). In the group of LMP, the HBT was positive in 201/237 (84.8%, 66 males, 135 females) and negative in 30/237 (12.6%, 11 males, 19 females) patients while six (2.5%, two males, four females) were hydrogen nonproducers (Figure 1 ). The prevalence of positive/negative tests was statistically different in the two groups (Po0.0001). Peak hydrogen concentration. The C max H 2 was 62.27s.d. 32.8 ppm in PMP patients and 83.9737.3 in LMP. The difference between PMP and LMP was statistically significant (Po0.001).
Area under the curve of H 2 concentration (C tot H 2 ). The area under the curve of hydrogen concentration from the 30-60 to 210-240 min interval, calculated as previously described, in patients with a positive test, was 66.5737.3 ppm/h in PMP and 88.9745.1 ppm/h in LMP patients. The difference was statistically significant (Po0.001).
First peak of increased H 2 excretion (T peak ). The time elapsing between administration of lactose and the first peak of increased hydrogen excretion showed a comparable pattern, corresponding, in most instances, to the second test hour in both study groups. The distribution of the T peak was very similar, being, respectively, 22.6% during the first hour, 36.3% during the second, 25.0% during the third and 16.1% during the fourth hour in PMP, and 32.8, 39.8, 20.4 and 7.0%, respectively, in LMP patients. Thus, the curve was slightly shifted to the right in PMP.
Symptoms during the HBT. During the lactose breath test and in the following 4 h, symptoms, consisting of gaseousness, gaseousness and pain, and bowel movements with loose stools, were reported, respectively, by 84/237 (35.4%) patients with PMP and 118/237 (49.7%) with LMP, and positive HBT (Table 1) . The difference was statistically significant (Po0.002). Only a few patients in the two study groups reported minor symptoms despite a negative HBT.
Methane production. During the HBT, methane excretion exceeded an increase of 100% and also exceeded 20 ppm, in 57/113 (50.4%) patients with negative HBT. The area under the curve (C tot CH 4 ) was 70.6763.8 ppm/h in these patients as compared to 54.2749.2 ppm/h (C tot CH 4 ) in those in whom basal values were not doubled. The mode of the first peak of CH 4 excretion was in the 90-120 min interval, which corresponds exactly to the T peak of hydrogen excretion. Methane excretion also doubled in 49/124 (39.5%) patients with a positive HBT.
Relationship between methane and hydrogen excretion. The hydrogen P 2 was 73.5736.8 ppm in those PMP patients with a two-fold increase in methane excretion (C tot H 2 71.6740.7 ppm/h) and 60.5726.6 ppm in those not showing a 100% increase in CH 4 excretion (C tot H 2 61.17 32.8 ppm/h). This finding is related to a higher proportion of severe lactose malabsorption (C max 480 ppm) and high H 2 excretion, in patients in whom CH 4 concentration was doubled during the test (20/49 vs 25/75).
Discussion
The ability to produce methane is related to the oxidation of hydrogen by methane-producing bacteria. The process of CH 4 production consumes 4 mol of hydrogen to reduce 1 mol of CO 2 to CH 4 , reducing volume and pressure of intracolonic gas (Wolin, 1981) . As expected, subjects with predominant CH 4 -producing flora excrete lower amounts of H 2 as compared to low CH 4 producers. Indeed, in our series, the peak values of H 2 excretion and the area under the curve in PMP showed lower values than in the control group, and the prevalence of H 2 nonproducers was higher. Also the trend of a longer interval between the ingestion of lactose and the first peak of H 2 excretion in PMP may be explained by the initial consumption of the gas . This finding is in keeping with previous observations, and does not necessarily imply a longer mouth to caecum transit time in CH 4 producers, as suggested by some authors (Stephen et al, 1986; Cloarec et al, 1990) .
The prevalence of a positive lactose breath test was surprisingly low in PMP as compared to the general normal Italian population (55-70%), and is only partially balanced by H 2 nonproducers (Burgio et al, 1984; Bozzani et al, 1986) . HBT was positive in 201 (84.8%) LMP, but only in 124 (52.3%) PMP patients. In the latter group, we would have expected similar overall figures, or the excretion of increased amounts of CH 4, as the availability of H 2 is the main limiting step for CH 4 production . Actually, the concentration of methane excretion doubled in 106/237 of PMP patients. Moreover, splitting these data, we observed that CH 4 excretion doubled in 57 out of 113 patients with a negative HBT (50.4%) and in 49/124 with a positive HBT (39.5%). This is exactly what would be expected considering that CH 4 production is associated with H 2 consumption. Moreover, a marked increase in CH 4 excretion was hardly ever observed after the rise in H 2 . Conversely, the increase in H 2 concentrations in expired air was associated with the reduction or suppression of CH 4 excretion in over 50% of cases.
On the other hand, the patients with a positive HBT and increased CH 4 excretion showed higher H 2 excretion rates than those in whom CH 4 excretion showed no increase during the test. This is in contrast to what might have been expected, and suggests that the mutual interference of differing bacterial species, and their metabolism, is far more complex than anticipated by in vitro fermentation studies. These data also indicate that PMP patients excrete less H 2 than LMP patients and that an HBT is burdened by a high false negative rate in those tests aimed at identifying 'lactose malabsorbers', in epidemiologic studies. The assumption that H 2 excretion is an effective indirect means for quantifying the amount of malabsorbed carbohydrates is questionable, at least in PMP. These data also suggest that the use of gas chromatography measuring H 2 excretion only is, in this respect, less than ideal. Conversely, if the test is aimed at identifying those patients with 'lactose intolerance', in which symptoms are, to some extent, related to the amount The difference between the two groups is not significant.
of gas produced in the colon, the measurement of H 2 seems to be adequate. The lower prevalence of severe lactose intolerance in PMP is, indeed, related to lower and slower H 2 excretion, as well as to a lower incidence of symptoms characteristic of lactose intolerance such as abdominal pain, gaseousness, bloating and diarrhoea.
